Program

Andreas Laner, PhD

Head of Genomics Program

Areas of Specialization

• Genetics of hereditary cancer syndromes
• Next-generation sequencing applications
• Interpretation and classification of sequence variants

Education & Experience

• Diploma in Biology, Ludwig Maximilian University, Munich
• PhD, Ludwig Maximilian University, Munich

Professional affiliations

• MGZ Munich, Head of Genomics Applications
• Member, European Society of Human Genetics
• Curator, Leiden Open Variation Database
• Organizational Committee, Variant Effect Prediction Training Course, Crete 2016
• Scientific Program Committee, 14th International Symposium on Variants in the Genome, Santiago de Compostela 2017 

A special interest in dysmorphology, in particular Coffin-Siris syndrome, and prenatal genetic testing.

Aleena studied Molecular and Biomedical Sciences at King’s College London. She joined the Quadram Institute Biosciences, UK to pursue her PhD in the field of Molecular Biology. Her PhD investigated the molecular and microbial changes in the gut-liver axis in response to the high-fibre and low-fibre Western diets. Aleena joined EMBL-EBI as an Ensembl Outreach Officer in 2021 and delivers training on Ensembl resources.

Aleena studied Molecular and Biomedical Sciences at King’s College London. She joined the Quadram Institute Biosciences, UK to pursue her PhD in the field of Molecular Biology. Her PhD investigated the molecular and microbial changes in the gut-liver axis in response to the high-fibre and low-fibre Western diets. Aleena joined EMBL-EBI as an Ensembl Outreach Officer in 2021 and delivers training on Ensembl resources.

Dr Fiona Cunningham is interested in problems where building large-scale systems for genomic data can lead to fundamental biological insights, particularly for understanding genomic variation. At EMBL-EBI she is responsible for genome interpretation and variation resources, and manual genome annotation (GENCODE). Her team developed Ensembl's Variant Effect predictor (VEP), the software tool for annotating variation data.

Fiona is part of the senior management for Ensembl (www.ensembl.org), a genome information system, and led the creation of the variation and phenotype data in Ensembl. Fiona shares leadership of Ensembl’s genome interpretation strategy and has overall responsibility for the variation resources in Ensembl and the International Genome Samples Resource (IGSR). In collaboration with the NHGRI, she is one of the PIs for the GWAS Catalog and formally, she led the Variant Annotation task team for the Global Alliance for Genomic Health project (GA4GH).  

Fiona is committed to open data and standards, in particular to share data and facilitate the transfer of research knowledge into valuable resources. In collaboration with the NCBI in the USA, Fiona leads the Matched Annotation from NCBI and EMBL-EBI (MANE) initiative, which aims to release a genome-wide transcript set with only one well-supported transcript per protein-coding locus. All transcripts in the MANE set will perfectly align to GRCh38 and will represent 100% identity between RefSeq and Ensembl/GENCODE. She also worked on the development of reference sequences, called LRG (Locus Reference Genomic) sequences, a stable data standard for reporting clinical variants with support for legacy sequences as part of the Transforming Genomic Medicine Initiative (TGMI). 

Prior to EMBL-EBI, Dr Cunningham worked at the Wellcome Trust Sanger Institute, Cold Spring Harbor Laboratory, and at deCODE Genetics in Iceland.

https://www.ebi.ac.uk/about/people/fiona-cunningham

Dr. Terence Murphy is the business owner for the RefSeq offering at the NCBI, and is the team lead for NCBI's eukaryote annotation group. He first joined the NCBI in 2006, and has spent the last 15 years working to apply the lessons learned from manual data curation to developing high-throughput methods to improve gene annotation in human, mouse and other eukaryotic species of relevance for improving human health. His team produces the NCBI RefSeq annotations for human, mouse, and hundreds of other eukaryotes, manages the datasets available in NCBI's Gene resource, and develops software for rapid high-quality genome annotation to support basic and applied research around the world.

Johan den Dunnen studied biology at the Catholic University Nijmegen (Nederland). In the same university he received his PhD in Molecular Biology for his work on the "Evolution of eye-lens crystallin genes". After his PhD he moved to the department of Human Genetics (Leiden University) and became involved in the search for the gene causing Duchenne/Becker muscular dystrophy. He is currently employed at the Center for Human and Clinical Genetics (Leiden University Medical Center, Leiden, Nederland), studying genetic disease in general and neuromuscular disorders (DMD/BMD, LGMD) in particular. As professor in "Medical Genomics" he focuses on the use of new high-throughput technology in research and diagnosis of genetic disease, in particular the development of methods to detect DNA variants and the application of next generation sequencing. To spread the laboratories knowledge on hereditary muscle disease he initiated the "Leiden Muscular Dystrophy pages" (http://www.DMD.nl). As part of these efforts he currently curates over 50 gene sequence variant databases. His group developed the freely available LSDB-in-a-Box software package LOVD, the Mutalyzer tool (HGVS sequence variant description) and he participates in the EU FP7 Gen2Phen project (WP leader for gene variant databases [LSDBs]). 

Associate Director UCSC Genome Browser

UC Santa Cruz Genomics Institute, Santa Cruz, CA, USA

Robert Kuhn studied biology and biochemistry at the University of Wisconsin and University of Cincinnati.  Following a masters degree in chemistry at the Oregon Health and Sciences University, he received his PhD in biochemistry and molecular biology at the University of California Santa Barbara, where he studied the centromeres of yeast.  He then studied photoreceptor genes in plants at UC Berkeley and has taught biochemistry, genetics and molecular biology at UC Santa Cruz.  Since joining the UCSC Genome Browser team in 2003, he has been instrumental in guiding the growth of the Browser and has shared the Browser in more than 300 presentations to scientists around the world.  

Associate Director UCSC Genome Browser

UC Santa Cruz Genomics Institute, Santa Cruz, CA, USA

Robert Kuhn studied biology and biochemistry at the University of Wisconsin and University of Cincinnati.  Following a masters degree in chemistry at the Oregon Health and Sciences University, he received his PhD in biochemistry and molecular biology at the University of California Santa Barbara, where he studied the centromeres of yeast.  He then studied photoreceptor genes in plants at UC Berkeley and has taught biochemistry, genetics and molecular biology at UC Santa Cruz.  Since joining the UCSC Genome Browser team in 2003, he has been instrumental in guiding the growth of the Browser and has shared the Browser in more than 300 presentations to scientists around the world.  

Associate Director UCSC Genome Browser

UC Santa Cruz Genomics Institute, Santa Cruz, CA, USA

Robert Kuhn studied biology and biochemistry at the University of Wisconsin and University of Cincinnati.  Following a masters degree in chemistry at the Oregon Health and Sciences University, he received his PhD in biochemistry and molecular biology at the University of California Santa Barbara, where he studied the centromeres of yeast.  He then studied photoreceptor genes in plants at UC Berkeley and has taught biochemistry, genetics and molecular biology at UC Santa Cruz.  Since joining the UCSC Genome Browser team in 2003, he has been instrumental in guiding the growth of the Browser and has shared the Browser in more than 300 presentations to scientists around the world.  

Andreas Laner, PhD

Head of Genomics Program

Areas of Specialization

• Genetics of hereditary cancer syndromes
• Next-generation sequencing applications
• Interpretation and classification of sequence variants

Education & Experience

• Diploma in Biology, Ludwig Maximilian University, Munich
• PhD, Ludwig Maximilian University, Munich

Professional affiliations

• MGZ Munich, Head of Genomics Applications
• Member, European Society of Human Genetics
• Curator, Leiden Open Variation Database
• Organizational Committee, Variant Effect Prediction Training Course, Crete 2016
• Scientific Program Committee, 14th International Symposium on Variants in the Genome, Santiago de Compostela 2017 

A group leader and principal investigator at the University Hospital of Dijon and the University of Burgundy since 2017. After completing his master’s degree at the University of Pisa (Italy), Antonio moved to Basel (Switzerland) where he was enrolled in the Friedrich Miescher Institute PhD program, obtaining his PhD in Neurobiology conferred by the University of Basel in 2013. As a post-doc he worked at the Novartis Institute for Biomedical Research, in the group of Safety Epigenetics, where he integrated genomic, transcriptomic and epigenomic data obtained from multiple preclinical species and human samples. 

Currently, he is interested in the implementation of novel omics technologies into the medical practice, to reduce wandering and diagnostic deadlock associated with unsolved rare genetic neurodevelopmental diseases. 

Anna is head of the Development and Technology Transfer department at the Munich Medical Genetics Centre since 2011. Anna moved from Barcelona to Munich in the year 2000 where she obtained her PhD in molecular biology by the Ludwig Maximilian University of Munich in the year 2005. As a post-doc she worked at the Helmholtz German Research Centre for Environmental Health in the Human Genetics Institute of Prof. Dr. Thomas Meitinger, where she managed the laboratory unit of the next-generation sequencing core facility. Her primary research area was genetic identification and molecular characterization of rare Mendelian diseases.  As specialist in high-throughput sequencing and data analysis, she focuses her professional career at MGZ on the interdisciplinary management of laboratory technology, bioinformatics, and scientific development. In particular the application of next generation sequencing and the development of bioinformatics methods to detect genomic variations for the diagnosis of genetic disease. She aims to achieve Best Practices for high-throughput sequencing data analysis depending on the type of variation of interest and the technology employed. Anna has contributed to publications on guidelines for utilization of next-generation sequencing approaches in genetic testing and she is also assessor of the External Quality Assessment scheme for Charcot-Marie-Tooth disease within the European Genetics Quality Network (EMQN) framework.

Leslie Matalonga obtained a PhD in Biomedicine (University of Barcelona) and worked at a clinical Group in Hospital Clínic de Barcelona for 7 years. Since 2017, Leslie joined the CNAG-CRG Bioinformatics Unit as Clinical Genomics Specialist. She works in the analysis and interpretation of genomic data from patients with rare diseases. She works in collaboration with the developer team of the RD-Connect GPAP (https://platform.rd-connect.eu/ ) and coordinates part of the new features to be added. She has been involved in several national and internal projects towards rare disease genomic diagnostics and research such as URD-Cat, NAGEN 1000G and Solve-RD, where she is leading a working group on exome re-analysis through APIs. She is also a member of the ELIXIR Rare Disease Community and is an author of 21 international publications.

Prof Makrythanasis received his Medical Degree from the University of Athens, Medical School, Greece and got his PhD from the same University in the field of Human Genetics. He got specialized in Medical Genetics in Geneva Switzerland and received his Privat Docent from the University of Geneva for his research in the identification of novel genes responsible for monogenic disorders through the study of consanguineous families. After his return in Greece he worked at the Greek Genome Center of the Biomedical Research Foundation of the Academy of Athens, before joining the Medical School of the University of Athens, where he currently holds the position of Assistant Professor in Medical Genetics.

Johan den Dunnen studied biology at the Catholic University Nijmegen (Nederland). In the same university he received his PhD in Molecular Biology for his work on the "Evolution of eye-lens crystallin genes". After his PhD he moved to the department of Human Genetics (Leiden University) and became involved in the search for the gene causing Duchenne/Becker muscular dystrophy. He is currently employed at the Center for Human and Clinical Genetics (Leiden University Medical Center, Leiden, Nederland), studying genetic disease in general and neuromuscular disorders (DMD/BMD, LGMD) in particular. As professor in "Medical Genomics" he focuses on the use of new high-throughput technology in research and diagnosis of genetic disease, in particular the development of methods to detect DNA variants and the application of next generation sequencing. To spread the laboratories knowledge on hereditary muscle disease he initiated the "Leiden Muscular Dystrophy pages" (http://www.DMD.nl). As part of these efforts he currently curates over 50 gene sequence variant databases. His group developed the freely available LSDB-in-a-Box software package LOVD, the Mutalyzer tool (HGVS sequence variant description) and he participates in the EU FP7 Gen2Phen project (WP leader for gene variant databases [LSDBs]). 

Andreas Laner, PhD

Head of Genomics Program

Areas of Specialization

• Genetics of hereditary cancer syndromes
• Next-generation sequencing applications
• Interpretation and classification of sequence variants

Education & Experience

• Diploma in Biology, Ludwig Maximilian University, Munich
• PhD, Ludwig Maximilian University, Munich

Professional affiliations

• MGZ Munich, Head of Genomics Applications
• Member, European Society of Human Genetics
• Curator, Leiden Open Variation Database
• Organizational Committee, Variant Effect Prediction Training Course, Crete 2016
• Scientific Program Committee, 14th International Symposium on Variants in the Genome, Santiago de Compostela 2017